NCT04843111
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- Pennsylvania Locations Swiftwater, Pennsylvania, United States
Clinical trial condition
Meningococcal Infection
Explore clinical trials studying Meningococcal Infection. Study availability and eligibility vary by location and protocol.
23 public trials
1 recruiting study
Meningococcal Infection trial results
Not Yet Recruiting
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China
NCT07710872
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
Not specified
NCT06228586
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- Investigational Site Number : 7040001 Hanoi, Vietnam
- Investigational Site Number : 7040002 Thái Bình, Vietnam
- Investigational Site Number : 7040003 Thái Bình, Vietnam
- Investigational Site Number : 7040004 Thái Bình, Vietnam
NCT01890759
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- Vadodara, Gujarat, India
- Kolkata, West Bengal, India
- Lucknow, India
- Vellore, India
Completed
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
NCT01049035
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- Birmingham, Alabama, United States
- Tuscaloosa, Alabama, United States
- Jonesboro, Arkansas, United States
- Little Rock, Arkansas, United States
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- Espoo Vaccine Research Clinic Espoo, Finland
- Helsinki South Vaccine Research Clinic Helsinki, Finland
- Oulu Vaccine Research Clinic Oulu, Finland
- Pori Vaccine Research Clinic Pori, Finland
Completed
Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose
NCT01543087
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC Chandler, Arizona, United States
- Clinical Research Advantage, Inc./ East Valley Family Physicians, PLC Chandler, Arizona, United States
- St. Joseph Heritage Healthcare Huntington Beach, California, United States
- Center For Clinical Trials, LLC Paramount, California, United States
NCT01340898
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Beirut, Lebanon
- GSK Investigational Site Durango, Mexico
NCT00631995
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- Herston, Australia
- Melbourne, Australia
- North Adelaide, Australia
- Perth, Australia
NCT01689155
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- Oakland, California, United States